nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB11—Progesterone—uterine cancer	0.397	0.482	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—uterine cancer	0.121	0.147	CbGbCtD
Clofazimine—ABCB1—Progesterone—uterine cancer	0.0681	0.0826	CbGbCtD
Clofazimine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0616	0.0747	CbGbCtD
Clofazimine—ABCB1—Dactinomycin—uterine cancer	0.054	0.0655	CbGbCtD
Clofazimine—CYP3A4—Progesterone—uterine cancer	0.0408	0.0495	CbGbCtD
Clofazimine—ABCB1—Etoposide—uterine cancer	0.0305	0.037	CbGbCtD
Clofazimine—Splenic infarction—Medroxyprogesterone Acetate—uterine cancer	0.0297	0.17	CcSEcCtD
Clofazimine—ABCB1—Doxorubicin—uterine cancer	0.0208	0.0252	CbGbCtD
Clofazimine—CYP3A4—Etoposide—uterine cancer	0.0183	0.0221	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—uterine cancer	0.0125	0.0151	CbGbCtD
Clofazimine—Thromboembolism—Progesterone—uterine cancer	0.00743	0.0424	CcSEcCtD
Clofazimine—Thromboembolism—Medroxyprogesterone Acetate—uterine cancer	0.00673	0.0384	CcSEcCtD
Clofazimine—Embolism venous—Progesterone—uterine cancer	0.00468	0.0267	CcSEcCtD
Clofazimine—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.0242	CcSEcCtD
Clofazimine—Embolism—Progesterone—uterine cancer	0.00368	0.021	CcSEcCtD
Clofazimine—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.019	CcSEcCtD
Clofazimine—Hepatomegaly—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.0173	CcSEcCtD
Clofazimine—Skin discolouration—Progesterone—uterine cancer	0.00261	0.0149	CcSEcCtD
Clofazimine—Bone pain—Progesterone—uterine cancer	0.00247	0.0141	CcSEcCtD
Clofazimine—Hepatomegaly—Dactinomycin—uterine cancer	0.00236	0.0135	CcSEcCtD
Clofazimine—Cystitis noninfective—Progesterone—uterine cancer	0.00231	0.0132	CcSEcCtD
Clofazimine—Cystitis—Progesterone—uterine cancer	0.00228	0.013	CcSEcCtD
Clofazimine—Bladder pain—Progesterone—uterine cancer	0.00214	0.0122	CcSEcCtD
Clofazimine—Thromboembolism—Epirubicin—uterine cancer	0.00213	0.0122	CcSEcCtD
Clofazimine—Cystitis noninfective—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.0119	CcSEcCtD
Clofazimine—Cystitis—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.0118	CcSEcCtD
Clofazimine—Lymphadenopathy—Progesterone—uterine cancer	0.00201	0.0115	CcSEcCtD
Clofazimine—Thromboembolism—Doxorubicin—uterine cancer	0.00197	0.0113	CcSEcCtD
Clofazimine—Bladder pain—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.011	CcSEcCtD
Clofazimine—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00807	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—uterine cancer	0.00134	0.00766	CcSEcCtD
Clofazimine—Weight decreased—Progesterone—uterine cancer	0.00134	0.00765	CcSEcCtD
Clofazimine—Skin discolouration—Etoposide—uterine cancer	0.00134	0.00764	CcSEcCtD
Clofazimine—Hyperglycaemia—Progesterone—uterine cancer	0.00134	0.00763	CcSEcCtD
Clofazimine—Drowsiness—Progesterone—uterine cancer	0.00132	0.00754	CcSEcCtD
Clofazimine—Depression—Progesterone—uterine cancer	0.00132	0.00752	CcSEcCtD
Clofazimine—Jaundice—Progesterone—uterine cancer	0.00129	0.00735	CcSEcCtD
Clofazimine—Body temperature increased—Carboplatin—uterine cancer	0.00127	0.00724	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—uterine cancer	0.00124	0.00709	CcSEcCtD
Clofazimine—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00694	CcSEcCtD
Clofazimine—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00692	CcSEcCtD
Clofazimine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00684	CcSEcCtD
Clofazimine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00682	CcSEcCtD
Clofazimine—Hepatitis—Progesterone—uterine cancer	0.00119	0.00677	CcSEcCtD
Clofazimine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00666	CcSEcCtD
Clofazimine—Visual impairment—Progesterone—uterine cancer	0.00114	0.00653	CcSEcCtD
Clofazimine—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00614	CcSEcCtD
Clofazimine—Embolism—Epirubicin—uterine cancer	0.00106	0.00602	CcSEcCtD
Clofazimine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00591	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—uterine cancer	0.000976	0.00557	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—uterine cancer	0.000975	0.00557	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—uterine cancer	0.000957	0.00546	CcSEcCtD
Clofazimine—Anaemia—Progesterone—uterine cancer	0.000954	0.00545	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—uterine cancer	0.000902	0.00515	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—uterine cancer	0.000885	0.00506	CcSEcCtD
Clofazimine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000865	0.00494	CcSEcCtD
Clofazimine—Oedema—Progesterone—uterine cancer	0.000843	0.00481	CcSEcCtD
Clofazimine—Hepatitis—Dactinomycin—uterine cancer	0.000838	0.00479	CcSEcCtD
Clofazimine—Anorexia—Progesterone—uterine cancer	0.000803	0.00459	CcSEcCtD
Clofazimine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000764	0.00436	CcSEcCtD
Clofazimine—Skin discolouration—Epirubicin—uterine cancer	0.00075	0.00428	CcSEcCtD
Clofazimine—Somnolence—Progesterone—uterine cancer	0.000749	0.00428	CcSEcCtD
Clofazimine—Decreased appetite—Progesterone—uterine cancer	0.000733	0.00418	CcSEcCtD
Clofazimine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00416	CcSEcCtD
Clofazimine—Fatigue—Progesterone—uterine cancer	0.000726	0.00415	CcSEcCtD
Clofazimine—Constipation—Progesterone—uterine cancer	0.000721	0.00411	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—uterine cancer	0.000707	0.00404	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—uterine cancer	0.000694	0.00396	CcSEcCtD
Clofazimine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000679	0.00388	CcSEcCtD
Clofazimine—Anaemia—Dactinomycin—uterine cancer	0.000675	0.00385	CcSEcCtD
Clofazimine—Body temperature increased—Progesterone—uterine cancer	0.000666	0.0038	CcSEcCtD
Clofazimine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.00379	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—uterine cancer	0.000662	0.00378	CcSEcCtD
Clofazimine—Jaundice—Etoposide—uterine cancer	0.000659	0.00376	CcSEcCtD
Clofazimine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000658	0.00376	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—uterine cancer	0.000654	0.00374	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—uterine cancer	0.000654	0.00373	CcSEcCtD
Clofazimine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000653	0.00373	CcSEcCtD
Clofazimine—Bladder pain—Epirubicin—uterine cancer	0.000612	0.0035	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—uterine cancer	0.000612	0.00349	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—uterine cancer	0.000605	0.00345	CcSEcCtD
Clofazimine—Asthenia—Progesterone—uterine cancer	0.000605	0.00345	CcSEcCtD
Clofazimine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000604	0.00345	CcSEcCtD
Clofazimine—Pruritus—Progesterone—uterine cancer	0.000596	0.0034	CcSEcCtD
Clofazimine—Oedema—Dactinomycin—uterine cancer	0.000596	0.0034	CcSEcCtD
Clofazimine—Diarrhoea—Progesterone—uterine cancer	0.000577	0.00329	CcSEcCtD
Clofazimine—Lymphadenopathy—Epirubicin—uterine cancer	0.000576	0.00329	CcSEcCtD
Clofazimine—Anorexia—Dactinomycin—uterine cancer	0.000568	0.00324	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—uterine cancer	0.000567	0.00323	CcSEcCtD
Clofazimine—Dizziness—Progesterone—uterine cancer	0.000557	0.00318	CcSEcCtD
Clofazimine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000548	0.00313	CcSEcCtD
Clofazimine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00054	0.00308	CcSEcCtD
Clofazimine—Vomiting—Progesterone—uterine cancer	0.000536	0.00306	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—uterine cancer	0.000533	0.00304	CcSEcCtD
Clofazimine—Rash—Progesterone—uterine cancer	0.000531	0.00303	CcSEcCtD
Clofazimine—Dermatitis—Progesterone—uterine cancer	0.000531	0.00303	CcSEcCtD
Clofazimine—Headache—Progesterone—uterine cancer	0.000528	0.00301	CcSEcCtD
Clofazimine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000522	0.00298	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000521	0.00297	CcSEcCtD
Clofazimine—Decreased appetite—Dactinomycin—uterine cancer	0.000518	0.00296	CcSEcCtD
Clofazimine—Fatigue—Dactinomycin—uterine cancer	0.000513	0.00293	CcSEcCtD
Clofazimine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000505	0.00288	CcSEcCtD
Clofazimine—Nausea—Progesterone—uterine cancer	0.000501	0.00286	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000492	0.00281	CcSEcCtD
Clofazimine—Anaemia—Etoposide—uterine cancer	0.000488	0.00279	CcSEcCtD
Clofazimine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000485	0.00277	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000482	0.00275	CcSEcCtD
Clofazimine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.00275	CcSEcCtD
Clofazimine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.00275	CcSEcCtD
Clofazimine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000478	0.00273	CcSEcCtD
Clofazimine—Body temperature increased—Dactinomycin—uterine cancer	0.000471	0.00269	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000455	0.0026	CcSEcCtD
Clofazimine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000454	0.00259	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—uterine cancer	0.000449	0.00256	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—uterine cancer	0.000447	0.00255	CcSEcCtD
Clofazimine—Asthenia—Dactinomycin—uterine cancer	0.000427	0.00244	CcSEcCtD
Clofazimine—Eosinophilia—Epirubicin—uterine cancer	0.000421	0.0024	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000415	0.00237	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—uterine cancer	0.000414	0.00236	CcSEcCtD
Clofazimine—Anorexia—Etoposide—uterine cancer	0.000411	0.00235	CcSEcCtD
Clofazimine—Diarrhoea—Dactinomycin—uterine cancer	0.000408	0.00233	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—uterine cancer	0.000389	0.00222	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000388	0.00221	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—uterine cancer	0.000384	0.00219	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—uterine cancer	0.000383	0.00219	CcSEcCtD
Clofazimine—Somnolence—Etoposide—uterine cancer	0.000383	0.00219	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—uterine cancer	0.000379	0.00216	CcSEcCtD
Clofazimine—Vomiting—Dactinomycin—uterine cancer	0.000379	0.00216	CcSEcCtD
Clofazimine—Rash—Dactinomycin—uterine cancer	0.000376	0.00214	CcSEcCtD
Clofazimine—Decreased appetite—Etoposide—uterine cancer	0.000375	0.00214	CcSEcCtD
Clofazimine—Fatigue—Etoposide—uterine cancer	0.000372	0.00212	CcSEcCtD
Clofazimine—Jaundice—Epirubicin—uterine cancer	0.000369	0.00211	CcSEcCtD
Clofazimine—Constipation—Etoposide—uterine cancer	0.000369	0.0021	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000359	0.00205	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—uterine cancer	0.000356	0.00203	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000355	0.00202	CcSEcCtD
Clofazimine—Nausea—Dactinomycin—uterine cancer	0.000354	0.00202	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—uterine cancer	0.000351	0.002	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—uterine cancer	0.000342	0.00195	CcSEcCtD
Clofazimine—Body temperature increased—Etoposide—uterine cancer	0.000341	0.00195	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—uterine cancer	0.00034	0.00194	CcSEcCtD
Clofazimine—Visual impairment—Epirubicin—uterine cancer	0.000328	0.00187	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—uterine cancer	0.000315	0.0018	CcSEcCtD
Clofazimine—Asthenia—Etoposide—uterine cancer	0.000309	0.00177	CcSEcCtD
Clofazimine—Pruritus—Etoposide—uterine cancer	0.000305	0.00174	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—uterine cancer	0.000303	0.00173	CcSEcCtD
Clofazimine—Diarrhoea—Etoposide—uterine cancer	0.000295	0.00168	CcSEcCtD
Clofazimine—Dizziness—Etoposide—uterine cancer	0.000285	0.00163	CcSEcCtD
Clofazimine—Vomiting—Etoposide—uterine cancer	0.000274	0.00156	CcSEcCtD
Clofazimine—Anaemia—Epirubicin—uterine cancer	0.000274	0.00156	CcSEcCtD
Clofazimine—Rash—Etoposide—uterine cancer	0.000272	0.00155	CcSEcCtD
Clofazimine—Dermatitis—Etoposide—uterine cancer	0.000272	0.00155	CcSEcCtD
Clofazimine—Headache—Etoposide—uterine cancer	0.00027	0.00154	CcSEcCtD
Clofazimine—Nausea—Etoposide—uterine cancer	0.000256	0.00146	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—uterine cancer	0.000253	0.00145	CcSEcCtD
Clofazimine—Oedema—Epirubicin—uterine cancer	0.000242	0.00138	CcSEcCtD
Clofazimine—Anorexia—Epirubicin—uterine cancer	0.00023	0.00132	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—uterine cancer	0.000224	0.00128	CcSEcCtD
Clofazimine—Somnolence—Epirubicin—uterine cancer	0.000215	0.00123	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—uterine cancer	0.000213	0.00122	CcSEcCtD
Clofazimine—Decreased appetite—Epirubicin—uterine cancer	0.00021	0.0012	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—uterine cancer	0.000208	0.00119	CcSEcCtD
Clofazimine—Constipation—Epirubicin—uterine cancer	0.000207	0.00118	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—uterine cancer	0.000199	0.00113	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—uterine cancer	0.000194	0.00111	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—uterine cancer	0.000193	0.0011	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—uterine cancer	0.000191	0.00109	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—uterine cancer	0.000191	0.00109	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—uterine cancer	0.000177	0.00101	CcSEcCtD
Clofazimine—Asthenia—Epirubicin—uterine cancer	0.000173	0.00099	CcSEcCtD
Clofazimine—Pruritus—Epirubicin—uterine cancer	0.000171	0.000976	CcSEcCtD
Clofazimine—Diarrhoea—Epirubicin—uterine cancer	0.000165	0.000944	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—uterine cancer	0.00016	0.000916	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—uterine cancer	0.00016	0.000912	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—uterine cancer	0.000158	0.000903	CcSEcCtD
Clofazimine—Vomiting—Epirubicin—uterine cancer	0.000154	0.000877	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—uterine cancer	0.000153	0.000873	CcSEcCtD
Clofazimine—Rash—Epirubicin—uterine cancer	0.000152	0.00087	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—uterine cancer	0.000152	0.000869	CcSEcCtD
Clofazimine—Headache—Epirubicin—uterine cancer	0.000151	0.000864	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—uterine cancer	0.000148	0.000844	CcSEcCtD
Clofazimine—Nausea—Epirubicin—uterine cancer	0.000144	0.000819	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—uterine cancer	0.000142	0.000812	CcSEcCtD
Clofazimine—Rash—Doxorubicin—uterine cancer	0.000141	0.000805	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—uterine cancer	0.000141	0.000804	CcSEcCtD
Clofazimine—Headache—Doxorubicin—uterine cancer	0.00014	0.0008	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—uterine cancer	0.000133	0.000758	CcSEcCtD
